Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 2
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.
Mayer MC, Berg JL, Perfler B, Hatzl S, Herzog SA, Bachmaier G, Berghold A, Reinisch A, Wölfler A, Sill H, Zebisch A. Mayer MC, et al. Among authors: perfler b. Ann Hematol. 2021 Nov;100(11):2845-2847. doi: 10.1007/s00277-021-04598-6. Epub 2021 Jul 22. Ann Hematol. 2021. PMID: 34291333 No abstract available.
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
Berg JL, Perfler B, Hatzl S, Uhl B, Reinisch A, Pregartner G, Berghold A, Penz T, Schuster M, Geissler K, Prokesch A, Müller-Tidow C, Hoefler G, Kashofer K, Wölfler A, Sill H, Caraffini V, Zebisch A. Berg JL, et al. Among authors: perfler b. Leukemia. 2021 May;35(5):1521-1526. doi: 10.1038/s41375-021-01161-0. Epub 2021 Feb 15. Leukemia. 2021. PMID: 33589750 Free PMC article. No abstract available.
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Berg JL, Perfler B, Hatzl S, Mayer MC, Wurm S, Uhl B, Reinisch A, Klymiuk I, Tierling S, Pregartner G, Bachmaier G, Berghold A, Geissler K, Pichler M, Hoefler G, Strobl H, Wölfler A, Sill H, Zebisch A. Berg JL, et al. Among authors: perfler b. Clin Epigenetics. 2021 Jan 6;13(1):1. doi: 10.1186/s13148-020-00979-2. Clin Epigenetics. 2021. PMID: 33407852 Free PMC article.
Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.
Caraffini V, Perfler B, Berg JL, Uhl B, Schauer S, Kashofer K, Ghaffari-Tabrizi-Wizsy N, Strobl H, Wölfler A, Hoefler G, Sill H, Zebisch A. Caraffini V, et al. Among authors: perfler b. Blood. 2018 Feb 15;131(7):826-830. doi: 10.1182/blood-2017-09-804906. Epub 2018 Jan 2. Blood. 2018. PMID: 29295844 Free PMC article. No abstract available.
Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.
Caraffini V, Geiger O, Rosenberger A, Hatzl S, Perfler B, Berg JL, Lim C, Strobl H, Kashofer K, Schauer S, Beham-Schmid C, Hoefler G, Geissler K, Quehenberger F, Kolch W, Athineos D, Blyth K, Wölfler A, Sill H, Zebisch A. Caraffini V, et al. Among authors: perfler b. Haematologica. 2020 Jan 31;105(2):375-386. doi: 10.3324/haematol.2018.209650. Print 2020. Haematologica. 2020. PMID: 31097632 Free PMC article.